Aimee S Weisner's Net Worth

$6.3 Million

Estimate Recalculated Apr 12, 2024 06:51PM EST

Who is Aimee S Weisner?

Aimee S Weisner has an estimated net worth of $6.3 Million. This is based on reported shares across multiple companies, which include Edwards Lifesciences Corp, ABBOTT MEDICAL OPTICS INC, GLAUKOS Corp, Oyster Point Pharma, Inc., LENSAR, Inc., and STAAR SURGICAL CO.

SEC CIK

Aimee S Weisner's CIK is 0001227308

Past Insider Trading and Trends

2023 was Aimee S Weisner's most active year for acquiring shares with 12 total transactions. Aimee S Weisner's most active month to acquire stocks was the month of April. 2009 was Aimee S Weisner's most active year for disposing of shares, totalling 18 transactions. Aimee S Weisner's most active month to dispose stocks was the month of January. 2005 saw Aimee S Weisner paying a total of $450,629.45 for 107,198 shares, this is the most they've acquired in one year. In 2005 Aimee S Weisner cashed out on 124,396 shares for a total of $2,507,262.79, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Edwards Lifesciences Corp (EW) Snapshot price: $89.7

CVP, General Counsel

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
May 9
Form 4
∞
1.68K
—
—
1.68K
May 12
Form 4
—
0
—
—
0
Feb 10
Form 3
—
0
—
—
0
No matching records found

ABBOTT MEDICAL OPTICS INC No price found

Executive Vice President

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-9.91K
$22.00
-$462,145.26
0
Feb 25 - Feb 26
Form 4
—
0
—
—
0
May 29
Form 4
—
0
—
—
0
Feb 11
Form 4
—
0
—
—
6.69K
Apr 27 - May 21
Form 4
-1.52%
-100.00
—
—
6.49K
Feb 2 - Apr 27
Form 4
—
0
—
—
0
Feb 6
Form 4
+75.65%
2.75K
—
—
6.39K
May 24
Form 4
—
0
$24.80
-$387,154.58
3.39K
Scheduled
Jul 26
Form 4
—
0
$23.53
-$1,669,478.75
3.39K
Scheduled
Jul 22
Form 4
—
0
—
—
0
May 26
Form 4
—
0
—
—
0
May 20
No matching records found

GLAUKOS Corp (GKOS) Snapshot price: $94.635

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+3.25%
895
—
—
28.4K
Jan 2
Form 4
+13.30%
3.23K
—
—
27.51K
Jun 1
Form 4
+41.19%
10K
$7.28
$72,750.00
34.28K
Mar 8
Form 4
+6.92%
1.57K
—
—
24.28K
Jan 3
Form 4
+23.79%
4.36K
—
—
22.71K
Jun 2
Form 4
+8.62%
1.46K
—
—
18.34K
Jan 3
Form 4
+40.00%
2K
$51.66
$103,320.00
7K
Aug 9
Form 4
+16.42%
2.38K
—
—
16.89K
Jun 3
Form 4
+7.25%
980
—
—
14.51K
Jan 4
Form 4
+40.52%
3.9K
—
—
13.53K
Jun 3
Form 4
+13.73%
1.16K
—
—
9.63K
Jan 2
Form 4
+45.66%
2.65K
—
—
8.46K
May 30
Form 4
+25.40%
1.18K
—
—
5.81K
Jan 2
Form 4
∞
4.63K
—
—
4.63K
May 31
Form 4
—
0
—
—
0
Dec 13
Form 4
—
0
—
—
0
Jun 2
Form 4
+100.00%
2.5K
$16.03
$40,075.00
5K
Mar 4
Form 4
∞
2.5K
$21.83
$54,575.00
2.5K
Nov 12
Form 4
—
0
—
—
0
Jul 23
Form 3
—
0
—
—
0
No matching records found

Oyster Point Pharma, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-36.76K
—
—
0
Jan 3
Form 4
+10.76%
3.57K
—
—
36.76K
Jun 6
Form 4
+11.66%
3.47K
—
—
33.19K
Jun 7
Form 4
+28.54%
6.6K
—
—
29.73K
Jun 8
Form 4
∞
23.13K
—
—
23.13K
Oct 31
Form 3
—
0
—
—
0
No matching records found

LENSAR, Inc. (LNSR) Snapshot price: $3.7

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+17.11%
9.29K
—
—
63.57K
May 25
Form 4
+44.23%
16.65K
$2.75
$45,779.25
54.28K
May 22
Form 4
+778.37%
33.35K
$2.56
$85,488.27
37.64K
May 17 - May 19
Form 4
∞
4.29K
—
—
4.29K
May 25
Form 4
—
0
—
—
0
May 18
Form 4
—
0
—
—
0
Mar 12
Form 4
—
0
—
—
0
Feb 1
Form 3
—
0
—
—
0
No matching records found